Return to study ST001391 main page
MB Sample ID: SA113316
Local Sample ID: | PTLDS_JHU_6PT |
Subject ID: | SU001465 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Select appropriate tab below to view additional metadata details:
Combined analysis:
Analysis ID | AN002320 |
---|---|
Analysis type | MS |
Chromatography type | Reversed phase |
Chromatography system | Agilent 6520 |
Column | Poroshell 120 EC-C8 (100 x 2.1mm,2.5um) |
MS Type | ESI |
MS instrument type | QTOF |
MS instrument name | Agilent 6520 QTOF |
Ion Mode | POSITIVE |
Units | counts |
MS:
MS ID: | MS002162 |
Analysis ID: | AN002320 |
Instrument Name: | Agilent 6520 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | LC-MS data were processed with MassHunter Profinder version B.08.00 and Mass Profiler Professional version B.14.9.01 (Agilent Technologies) to identify differentiating molecular features (MFs; metabolites defined by a retention time and accurate mass) between PTLDS and non-PTLDS patients at baseline, post-treatment and one-year follow-up in cohort-one. The biosignature-MFs determined using cohort-one were targeted in patient samples from cohort-two using MassHunter Profinder. |
Ion Mode: | POSITIVE |
Capillary Voltage: | 4000 |
Dry Gas Flow: | 10 l/min |
Dry Gas Temp: | 310 |
Fragment Voltage: | 120 |
Nebulizer: | 45 psi |
Octpole Voltage: | 750 V |